09:00 – 09:05 Welcome and introduction – Nadine Dorries MP
Minister of State for Mental Health, Suicide Prevention and Patient Safety
09:05 – 09:10 Why are we having this conference? – Edward Morris
President of the Royal College of Obstetricians & Gynaecologists, Chair of Group B Strep Support and morning Chair
09:10 – 09:40 Prevention of GBS in Mothers, Fetuses and Babies: A Vision – Dr Carol J Baker, MD
Professor of Pediatrics, McGovern Medical School, University of Texas, Sabin Gold Medal winner, National Academy of Sciences, USA
09:40 – 10:00 Insights from surveillance of infant GBS disease in England – Theresa Lamagni
Senior Epidemiologist. Healthcare-Associated Infection & Antimicrobial Resistance, Public Health England.
10:00 – 10:10 BREAK
10:10 – 10:30 Group B Streptococcus (GBS) screening recommendation and evidence gaps – Anne Mackie
Director of Screening for Public Health England. Director of Programmes for the UK National Screening Committee.
10:30 – 10:40 Royal College of Obstetricians and Gynaecologists Guideline on the Prevention of Early-Onset Neonatal Group B Streptococcal Disease – Philip Steer
Emeritus Professor of Obstetrics and Gynaecology in the Faculty of Medicine, Imperial College London. Representative of the RCOG’s 2017 Guidelines Group.
10:40 – 10:55 Group B Strep prevention in the UK: past, present and future – Jane Plumb & Philip Steer
Jane Plumb – Chief Executive of Group B Strep Support & Philip Steer – Emeritus Professor of Obstetrics and Gynaecology in the Faculty of Medicine, Imperial College London.
10:55 – 11:15 Q&A and Discussion – Chaired by Edward Morris
11:15 – 11:25 BREAK
11:25 – 11:40 Accuracy of a rapid test in early labour for maternal group B Strep colonisation and its potential to reduce antibiotic usage in mothers with risk factors – the GBS2 study. – Shakila Thangaratinam
Professor of Maternal and Perinatal Health, University of Birmingham, Joint Director of WHO Collaborating Centre for Global Women’s Health
11:40 – 12:00 NIHR-funded national trial comparing testing pregnant women for GBS vs current UK practice: GBS3 trial – Jane Daniels & Kate Walker
Jane Daniels – Professor of Clinical Trials, University of Nottingham. Kate Walker – Associate Professor of Obstetrics and consultant obstetrician, University of Nottingham.
12:00 – 12:10 Parents’ view. – Speaker TBA
12:10 – 12:30 Q&A and Discussion – Chaired by Edward Morris
12:30 – 13:00 Lunch Break
13:00 – 13:05 Afternoon session introduction – Kathryn Gutteridge
President of the Royal College of Midwives, Trustee of Group B Strep Support and Afternoon Chair
13:05 – 13:20 Learning from when things go wrong with detection, escalation and treatment of group B Strep in maternity care. – Annette Anderson
Head of the Early Notification Scheme (clinical), NHS Resolution.
13:20 – 13:40 How best to detect group B Strep: technique of taking samples, culture methods and PCR tests – Androulla Efstratiou
Professor, Imperial College London and Director, WHO Global Collaborating Centre for Diphtheria & Streptococcal Infections
13:40 – 14:00 Do differences between strains of group B Strep matter? – Kirsty Le Doare
Professor of Vaccinology and Immunology, St George’s University of London
14:00 – 14:20 Using Whole Genome Sequencing (WGS) to study the evolution and genetic diversity of Group B Streptococcus – Dorota Jamrozy
Postdoctoral Fellow, the Wellcome Sanger Institute
14:20 – 14:40 Q&A and Discussion – Chaired by Kathryn Gutteridge
14:40 – 14:50 BREAK
14:50 – 15:10 Detecting group B Strep infection in the newborn – Alison Bedford Russell
Deputy Chief of Neonatal Clinical Services at Sidra Medicine, Doha, Qatar
15:10 – 15:30 Do antibiotics given in labour for group B Strep have a harmful effect on the neonatal microbiome? – Mark Turrentine
Professor, Baylor College of Medicine Department of Obstetrics & Gynecology, Houston Texas
15:30 – 15:50 Q&A and Discussion – Chaired by Kathryn Gutteridge
15:50 – 16:00 BREAK
16:00 – 16:10 Parents’ view – TBA
16:10 – 16:30 20 million pregnant women worldwide with GBS: deaths and new data on long-term outcomes. – Joy Lawn
Professor of Maternal, Reproductive and Child Health, Director of the London School of Hygiene & Tropical Medicine Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre.
16:30 – 16:50 Progress towards a Group B Strep vaccine: Trials & Tribulations. – Paul Heath
Professor of Paediatric Infectious Diseases at St George’s University of London
16:50 – 17:00 Progress in developing a six valent vaccine for the prevention of neonatal Group B streptococcal invasive disease – Dr Annaliesa S Anderson
Chief Scientific Officer Bacterial Vaccines, Pfizer
17:00 – 17:20 Final questions, summary and conclusions. Edward Morris and Kathryn Gutteridge
17:20 Conference ends
The full programme is recorded and made available to those who have registered.